Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(20):1519; doi:10.1093/jnci/94.20.1519
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 20, 1519, October 16, 2002
© 2002 Oxford University Press

NEWS

Would Central Review Streamline the Clinical Trials Process?

Tom Reynolds

The first 10% of the full text of this article appears below.

Given the lack of structure for risk/benefit decision-making by institutional review boards, should a formal system be put in place to standardize the process?

"I think it would be desirable, but I think it’s unlikely that it’s ever going to happen," said . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
Resources
J Natl Cancer Inst, May 7, 2003; 95(9): 637 - 637.
[Full Text]